SABCS 2022 highlights

(4:8)

SABCS 2022 highlights

(1:6)

SABCS 2022 takeaways

(2:)

SABCS 2022: clinical trial highlights

(1:25)

Dr. Bora Lim | Challenging Types of Breast Cancer | SABCS 2022 | Education Session

(1:51:16)

What to look out for at SABCS 2022

(44)

SABCS 2022: key highlights

(51)

The San Antonio Breast Cancer Symposium (SABCS) 2022

(56)

SABCS 2022: DESTINY-Breast02 + DESTINY-Breast03

(2:16)

Key takeaways from SABCS 2022

(1:3)

Highlights in HER2-low breast cancer at SABCS 2022

(32)

Epic Sciences DefineMBC Launch - SABCS 2022

(3:31)

Key highlights from SABCS 2022

(55)

Key takeaways from SABCS 2022

(46)

Key data at SABCS 2022

(1:16)

Mafalda Oliveira, SABCS 2022: Camizestrant vs fulvestrant for advanced ER+ HER2- breast cancer

(6:55)

Discussion highlights from SABCS 2022

(1:31)

SABCS 2022 key takeaways: optimizing treatment sequencing strategies

(1:42)

Dr. Seema Khan | SABCS 2022 | Educational Session

(2:2:8)

Key data from the San Antonio Breast Cancer Symposium (SABCS) 2022

(2:57)